Uterine myomas: management.
OBJECTIVE
To review the currently available literature regarding the current management alternatives available to women with uterine myomas.


METHODS
Literature review of 198 articles pertaining to uterine myomas.


RESULTS
Many advances have been made in the management of uterine myomas. Watchful waiting; medical therapy; hysteroscopic myomectomy; endometrial ablation; laparoscopic myomectomy; abdominal myomectomy; abdominal, vaginal, and laparoscopic hysterectomy; uterine artery embolization; uterine artery occlusion; and focused ultrasound are now available.


CONCLUSIONS
Many options are now available to women with uterine myomas. The presently available literature regarding the treatment of myomas is summarized.
Parker
William H
WH
Department of Obstetrics and Gynecology, UCLA School of Medicine, Santa Monica, California 90401, USA. wparker@ucla.edu
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005260:Female; D005298:Fertility; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D013509:Gynecologic Surgical Procedures / Q000009:adverse effects; D006801:Humans; D007434:Intrauterine Devices; D007889:Leiomyoma / Q000175:diagnosis / Q000628:therapy; D008593:Menopause / Q000502:physiology; D008954:Models, Biological; D009214:Myoma / Q000175:diagnosis / Q000628:therapy*; D013513:Obstetric Surgical Procedures / Q000009:adverse effects; D011247:Pregnancy; D011292:Premedication; D011374:Progesterone / Q000008:administration & dosage; D011379:Prognosis; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000628:therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone